E
Hepion Pharmaceuticals, Inc. HEPA
$0.2975 $0.01294.53% NASDAQ
Recommendation
Prev Close
$0.2846
Volume
2,902,925
Avg Vol (90D)
3,169,971
Market Cap
$3.12M
Dividend & Yield
--
52-Week Range
$0.25 - $79.50
P/E (TTM)
--
EPS (TTM)
-$109.29
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Short Interest in Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA) Increases By 25.2%
4/21/2025 - Ticker Report
Hepion Pharmaceuticals (HEPA) Announces $9M Public Offering Launch
4/9/2025 - GuruFocus
Hepion Pharmaceuticals (HEPA) to Implement 1-for-50 Reverse Stock Split
4/9/2025 - GuruFocus
Hepion Pharmaceuticals (HEPA) Ends Merger with Pharma Two B
4/9/2025 - GuruFocus
Hepion Pharmaceuticals trading halted, news pending
3/17/2025 - TipRanks Financial Blog
Hepion Pharmaceuticals trading halted, news pending
3/17/2025 - The Fly
Hepion Pharmaceuticals Announces Reverse Stock Split
3/14/2025 - GuruFocus
Hepion Pharmaceuticals announces 1-for-50 reverse stock split
3/14/2025 - Seeking Alpha - Healthcare
Hepion Pharmaceuticals announces 1-for-50 reverse stock split
3/14/2025 - TipRanks Financial Blog
Hepion Pharmaceuticals announces 1-for-50 reverse stock split
3/14/2025 - The Fly
Hepion Pharmaceuticals Announces Reverse Stock Split
3/14/2025 - Globe Newswire
Hepion Pharmaceuticals launches public offering for proceeds of up to $9M; shares tumble
1/22/2025 - SeekingAlpha.com: All News
Hepion Pharmaceuticals launches public offering for proceeds of up to $9M; shares tumble
1/22/2025 - Seeking Alpha - Healthcare
Hepion Pharmaceuticals announces $9M public offering
1/22/2025 - The Fly
Hepion Pharmaceuticals Announces $9.0 Million Public Offering
1/22/2025 - GuruFocus
Hepion Pharmaceuticals Announces $9.0 Million Public Offering
1/22/2025 - Globe Newswire
Hepion Pharmaceuticals files to sell common stock, warrants
12/26/2024 - SeekingAlpha.com: All News
Hepion Pharmaceuticals files to sell common stock, warrants, no amount given
12/26/2024 - TipRanks Financial Blog
Hepion Pharmaceuticals files to sell common stock, warrants, no amount given
12/26/2024 - The Fly
Reviewing Hepion Pharmaceuticals (NASDAQ:HEPA) and Novo Nordisk A/S (NYSE:NVO)
12/21/2024 - Ticker Report
Hepion Pharmaceuticals Terminates Merger with Pharma Two B
12/11/2024 - TipRanks Financial Blog
Hepion Pharma Announces Termination Of Merger Deal With Pharma Two B, Stock Falls
12/11/2024 - RTT News - Momentum Stocks
Hepion Pharmaceuticals announces termination of merger agreement with Pharma Two B
12/11/2024 - Seeking Alpha - Healthcare
Hepion Pharmaceuticals terminates merger agreement with Pharma Two B
12/11/2024 - The Fly
Hepion Pharmaceuticals, Inc. Announces Termination of Merger Agreement with Pharma Two B Ltd.
12/11/2024 - GuruFocus
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
-$19.32M
EBIT (TTM)
-$19.35M
Net Income (TTM)
-$13.19M
Balance Sheet
Total Assets (Q)
$1.61M
Total Debt (Q)
$2.90M
Total Liabilities (Q)
$3.48M
Book Value Per Share (Q)
-$25.57
Cash Flow
Cash from Operations (TTM)
-$18.22M
Cash from Investing (TTM)
-$600.00K
Cash from Financing (TTM)
$4.35M
Net Change in Cash (TTM)
-$14.38M
Filings
Filing Date
Tuesday, April 8, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 19 and 23 (est)
Price History
Loading...
Beta
0.26
7-Day Total Return
2.59%
30-Day Total Return
-62.81%
60-Day Total Return
-96.35%
90-Day Total Return
-98.79%
Year to Date Total Return
-98.80%
1-Year Total Return
-99.59%
2-Year Total Return
-99.95%
3-Year Total Return
-99.97%
5-Year Total Return
-99.98%
52-week Low
Apr 22, 2025 - $0.25
52-week High
May 03, 2024 - $79.50
Valuation
Market Cap
$3.12M - Nano Cap
Enterprise Value
$7.31M
Price/Sales (TTM)
--
Price/Book (Q)
-0.01
Dividends and Shares
Shares Outstanding
139.30K
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
hepionpharma.com
Phone Number
(732) 902-4000
Address
55 Madison Avenue
Suite 400 - PMB No. 4362
Morristown, NJ 07960
Country
United States
Year Founded
2013
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Hepion Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatment for hepatocellular carcinoma (HCC) and other chronic liver diseases in the United States. It... more
NASDAQ 05/05/2025 4:00PM Eastern Quotes delayed